Skip to main content
Premium Trial:

Request an Annual Quote

NCI Renews License for Genomatix Software

NEW YORK (GenomeWeb News) - The National Cancer Institute has renewed and extended a software licensing agreement with Genomatix Software’s US subsidiary, the Munich, Germany-based company said today.
 
Genomatix said the agreement marks the fourth consecutive year of the license with NCI.
 
Genomatix opened its US subsidiary earlier this year.
 
“We are extremely pleased with our progress in putting the US company on its feet, and the renewal with NCI/NIH is a huge step in firmly establishing our presence here”, said Peter Grant, CEO of the US company, in a statement.
 
Specific terms of the agreement were not released.
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.